Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000018

Chief Technology Officer acquired 16,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kurtoglu Metin · Chief Technology Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-02 Grant or award : show line 1 in the form +16,100 67,133 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-02 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +47,400 47,400 D
Loading xslF345X05/wk-form4_1736198370.xml…